STEK
Stemtech CorpCompany with tickers: STEK
CIK
1511820
CUSIP
85859W102
Shares Outstanding
2,067,960,034
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $2,876,380 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Cost of Revenue | $566,940 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Gross Profit | $2,309,440 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Operating Expenses | $5,018,487 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Research & Development | $0 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Operating Income | $-2,709,047 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| Net Income | $-4,046,705 | USD | 2025-12-31 | 10-K | 2026-05-29 |
| EPS (Basic) | $-0.02 | USD/shares | 2025-12-31 | 10-K | 2026-05-29 |
| EPS (Diluted) | $-0.02 | USD/shares | 2025-12-31 | 10-K | 2026-05-29 |